Company / Interest Expense
Evolent Health, Inc. Interest Expense History
FY2016-FY2023 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Interest Expense
$54.2M
FY2023
5-year range
$15.6M / $54.2M
FY2019-FY2023
Trend
+248.1%
vs FY2022
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Interest Expense changed +248% YoY in FY2023, a notable deviation from the 7-year average annual change of +269%.
Based on SEC 10-K filings.
$54M in FY2023 with a 5-year CAGR of +58.1%.
Increased from $25M to $54M over the past 2 years.
Interest Expense over time
Growth rates
- 3-Year CAGR
- +24.2%
- 5-Year CAGR
- +58.1%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of +58.1%, indicating consistent growth.
- In FY2023, interest expense increased 248.1% year-over-year.
- Lowest interest expense in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score -0.84 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Interest ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | $54.2M | +248.1% |
| FY2022 | $15.6M | -38.8% |
| FY2021 | $25.4M | -10.2% |
| FY2020 | $28.3M | +94.6% |
| FY2019 | $14.6M | +165.4% |
| FY2018 | $5.5M | +50.8% |
| FY2017 | $3.6M | +1372.1% |
| FY2016 | $247.0K | - |
As of FY2023 · SEC Form 10-K · Last checked Jun 21, 2026